Question:

When do the new level II codes Q5108 and Q5110 take effect?

Answer:

The effective date for code Q5108–injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg—is July 12, 2018. For Q5110–injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram—the effective date is October 1, 2018. The implementation date for both codes is October 1, 2018. This information can be found at https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R4134CP.pdf.

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.